Sector
PharmaceuticalsOpen
₹18.1Prev. Close
₹18.28Turnover(Lac.)
₹38.25Day's High
₹19Day's Low
₹17.952 Week's High
₹2752 Week's Low
₹9.29Book Value
₹11.11Face Value
₹10Mkt Cap (₹ Cr.)
37.08P/E
92.7EPS
0.2Divi. Yield
029 Aug 2024
12:00 AM
AGM
Announcement Date: 29 Aug, 2024
21 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 20 | 10 | 6.93 | 6.93 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 1.84 | 11.43 | 7.02 | 7.11 |
Net Worth | 21.84 | 21.43 | 13.95 | 14.04 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 10.57 | 11.72 | 5.16 | 1.91 |
yoy growth (%) | -9.78 | 126.88 | 169.65 | -11.76 |
Raw materials | -7.51 | -7.88 | -3.67 | -1.16 |
As % of sales | 71.04 | 67.21 | 71.15 | 60.54 |
Employee costs | -0.82 | -0.79 | -0.57 | -0.58 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 0.57 | 0.64 | 0.25 | 0.03 |
Depreciation | -0.46 | -0.32 | -0.27 | -0.22 |
Tax paid | -0.19 | -0.32 | -0.11 | 0 |
Working capital | 0.46 | -1.55 | -1.01 | 1.02 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -9.78 | 126.88 | 169.65 | -11.76 |
Op profit growth | -90.18 | -648.3 | -65.87 | 1,564.22 |
EBIT growth | -5.02 | 160.32 | 142.9 | -15.45 |
Net profit growth | 19.13 | 132.16 | 503.96 | 157.95 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,669.3 | 93.52 | 4,00,520.99 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,613.75 | 79.48 | 1,75,574.28 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,512.75 | 25.39 | 1,22,186 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,321.2 | 20.61 | 1,10,263.53 | 1,200.7 | 0.61 | 5,546.3 | 345.76 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,225.7 | 57.29 | 1,09,167.44 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Executive Director
Shruti Y Shah
Chairman (Non-Executive)
Yogesh M Shah
Managing Director
Bhavin S Shah
Company Sec. & Compli. Officer
Rony M Shah
Independent Director
Chetan H Mehta
Independent Director
Prakash C Shah
Independent Director
Nilesh Kantilal Shah
629-A 1st Floor Gazdar House,
JSS Marg Nr Kalbadevi Post Off,
Maharashtra - 400002
Tel: 91-22-22018582
Website: http://www.veerhealthcare.net
Email: [email protected]
9 ShivShakti Indl Es,
J R Boricha Marg, Lower Parel,
Mumbai - 400 011
Tel: 91-22-23016761/8261
Website: -
Email: -
Summary
Veerhealth Care Limited was originally incorporated on 10 July, 1992 as Niyati Leasing Limited to start business in Investment and Finance. The main objects of the Company in 1998 got changed and acc...
Read More
Reports by Veerhealth Care Ltd
What is the Veerhealth Care Ltd share price today?
What is the Market Cap of Veerhealth Care Ltd?
What is the PE and PB ratio of Veerhealth Care Ltd?
What is the 52 Week High and Low of Veerhealth Care Ltd?
What is the CAGR of Veerhealth Care Ltd?
What is the shareholding pattern of Veerhealth Care Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.